No abstract

BACKGROUND: Globally, patterns of the use of psychoactive substances have been changing. OBJECTIVE: To evaluate the trend in two five-year periods,

Objective: The aim of this study was to assess the prevalence and correlates of anxiety and depression among caregivers of children with seizure disorders. Methods: Two hundred and two caregivers of children with seizure disorders were administered socio-demographic questionnaires at the Child and Adolescent Outpatient Clinic between October 2011 and March 2012. The Structured Clinical Interview for DSM-IV axis 1 Diagnosis (SCID) was used for diagnosis of Generalized Anxiety Disorder and Major Depression. Results: One hundred and forty six (72%) of the carers were females, with mothers of patients accounting for 66% of respondents. The prevalence of generalized anxiety among the respondents was 12%, while that of major depressive disorder was 50.5%. The socio-demographic characteristics of carers associated with psychiatric morbidity included older age range (χ 2 =18.67, p=0.001), being employed (χ 2 =10.41, p=0.015), longer duration of care (χ 2 =18.07, p=0.001) and being patients' mother (χ 2 =10.17, p=0.032). Conclusion: Depression and anxiety are common among caregivers of children with seizure disorders. Caregivers' socio-demographic characteristics and patients' clinical variables are associated with prevalence of anxiety and depression. These findings suggest the need to adopt a holistic approach to the detection of these disorders and developing adequate intervention for these caregivers.

BackgroundNigeria, the most populous country in Africa and the 8th most populous in the world with a population of over 154 million, does not have current data on substance abuse treatment demand and treatment facilities; however, the country has the highest one-year prevalence rate of Cannabis use (14.3%) in Africa and ranks third in Africa with respect to the one-year prevalence rate of cocaine (0.7%) and Opioids (0.7%) use. This study aimed to determine the types, spread and characteristics of the substance abuse treatment centers in Nigeria.MethodsThe study was a cross sectional survey of substance abuse treatment centers in Nigeria. Thirty-one units were invited and participated in filling an online questionnaire, adapted from the European Treatment Unit/Program Form (June 1997 version).ResultsAll the units completed the online questionnaire. A large proportion (48%) was located in the South-West geopolitical zone of the country. Most (58%) were run by Non-Governmental Organizations. Half of them performed internal or external evaluation of treatment process or outcome. There were a total of 1043 for all categories of paid and volunteer staff, with an average of 33 staff per unit. Most of the funding came from charitable donations (30%). No unit provided drug substitution/maintenance therapy. The units had a total residential capacity of 566 beds. New client admissions in the past one year totalled 765 (mean = 48, median = 26.5, min = 0, max = 147) and 2478 clients received services in the non-residential units in the past year. No unit provided syringe exchange services.ConclusionsThe study revealed a dearth of substance abuse treatment units (and of funds for the available ones) in a country with a large population size and one of the highest prevalence rates of substance abuse in Africa. The available units were not networked and lacked a directory or an evaluation framework. To provide an environment for effective monitoring, funding and continuous quality improvement, the units need to be organized into a sustainable network.

No abstract

No abstract

No abstract

Background: Despite several studies on the prevalence and pattern of substance use in Nigeria, there is little information on substance use in patients diagnosed with serious mental illness (SMI) such as schizophrenia and bipolar affective disorder (BD).Aim: The aim of the study was to compare the pattern of psychoactive substance use among outpatients with BD and schizophrenia.Setting: The study was conducted in a neuropsychiatric hospital in Nigeria.Methods: Seventy five consecutive patients with a MINI-PLUS diagnosis of BD were compared with an equal number of patients obtained by systematic random sampling with a MINI-PLUS diagnosis of schizophrenia.Results: The respondents with schizophrenia were aged 18–59 years (37.2 ± 9.99) and were predominantly young adult (49, 65.3%), men (46, 61.3%), who were never married (38, 50.7%). Overall, lifetime drug use prevalence was 52%, while for current use, overall prevalence was 21.3%. Participants with BD were aged 18–63 years (36.7 ± 10.29) and were predominantly young adult (53, 70.7%), women (44, 58.7%), who were married (32, 42.7%), with tertiary education (31, 41.3%). Overall, lifetime drug use prevalence was 46.7%, while current overall prevalence was 17.3%. These rates (lifetime and current) for both diagnostic groups are higher than what was reported by the World Health Organization in the global status report of 2014 (0% – 16%). The statistically significant difference between the two diagnostic groups was related to their sociodemographic and clinical variables and psychoactive substance use.Conclusion: Psychoactive substance use remains a burden in the care of patients diagnosed with schizophrenia and BD. Future policies should incorporate routine screening for substance use at the outpatient department with a view to stemming the tide of this menace.